Acromegaly Clinical Trial
Official title:
Assessment of Airway in Patients With Acromegaly Undergoing Surgery: Predicting Successful Tracheal Intubation
Acromegaly is associated with increased risk of difficult intubation and its management. The
overall incidence of difficult intubation in patients suffering from acromegaly is four to
five times more than those without acromegaly.The difficult intubation scenario in these
patients can be managed by various methods ranging from awake fiberoptic intubation to
tracheostomy. Difficult tracheal intubation accounts for 17% of respiratory-related injuries
and results in significant morbidity and mortality in general population. In patients with
acromegaly, inability to mask ventilate or intubate can lead to 28% of all anesthesia
related deaths. Therefore, the need and importance of airway assessment in patients with
acromegaly cannot be overemphasized. Various tests of airway assessment have to be used to
assess difficult airway and tracheal intubation in acromegalics.
The investigators aim to assess the various tests of airway assessment affecting the outcome
of patients with acromegaly undergoing pituitary surgery and identify which was best suited.
All the patients of either gender, diagnosed as a case of acromegaly scheduled for pituitary
surgery will be enrolled. This observational study will be conducted over a period of 3
years. A written informed consent will be taken from all the patients. The clinical
diagnosis will be made on the basis of growth hormone (GH) levels and magnetic resonance
imaging (MRI) findings. All patients will be evaluated preoperatively, a day before surgery
by an independent observer. Airway assessment for difficult intubation will be performed
using Modified Mallampati classification in sitting and supine position followed by mouth
opening, upper lip bite test, measurement of thyromental, thyrohyoid, sternomental and
hyomental distance. Next the length of upper incisors, presence of receding mandible and
neck movement will be checked. An associated history of OSA will also be taken in to account
for assessing the difficult intubation followed by OSA grading in acromegalic patients
posted for pituitary surgery. In situation of difficult tracheal intubation the fiberoptic
intubation would be the preferred choice, which is a gold standard.
General anesthesia will be induced with fentanyl 2µg/kg, propofol 2 mg/kg and rocuronium
1mg/kg. After 90 seconds of mask ventilation, laryngoscopy will be performed with an
appropriate sized Macintosh laryngoscope and thereafter Cormac lehane grading will be noted.
External laryngeal manipulation (ELM) if carried out will be noted. A standard anesthesia
protocol will be followed. After completion of the surgery, neuromuscular blockade will be
reversed with neostigmine 0.05mg/kg and glycopyrrolate 0.01mg/kg intravenously. Once the
patient follows the verbal command and respiratory parameters are satisfactory, endotracheal
tube will be removed. All patients will be shifted to neurosurgical ICU for observation and
supportive management.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06344650 -
Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess. Cross-sectional and Prospective Study
|
||
Active, not recruiting |
NCT02092129 -
Pituitary Histopathology and Hyperprolactinaemia and Risk of Glucose Metabolic Disturbances in Acromegaly.
|
N/A | |
Completed |
NCT02012127 -
Description of Sign-and-symptom Associations at Acromegaly Diagnosis.
|
||
Active, not recruiting |
NCT01265121 -
Sleep Apnea Syndrome on Acromegaly: Impact of the Treatment on the Carbohydrates Metabolism.
|
N/A | |
Terminated |
NCT00765323 -
Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly
|
Phase 3 | |
Completed |
NCT00500227 -
Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
|
||
Completed |
NCT00531908 -
Physiopathology of Sodium Retention in Acromegaly
|
N/A | |
Completed |
NCT01278342 -
Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients
|
Phase 4 | |
Active, not recruiting |
NCT01809808 -
A Prospective Study of Outcome After Therapy for Acromegaly
|
||
Completed |
NCT00145405 -
Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction
|
Phase 4 | |
Completed |
NCT00210457 -
Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 mg) in Acromegalic Patients
|
Phase 3 | |
Recruiting |
NCT05401084 -
Diet in the Management of Acromegaly
|
N/A | |
Recruiting |
NCT00005100 -
Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
|
N/A | |
Completed |
NCT00521300 -
Preoperative Octreotide Treatment of Acromegaly
|
Phase 4 | |
Completed |
NCT03548415 -
Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands
|
Phase 2 | |
Not yet recruiting |
NCT04066569 -
Reproducibility and Utility of OGTT in Acromegaly
|
N/A | |
Not yet recruiting |
NCT05298891 -
Hypoproteic Diet in Acromegaly
|
N/A | |
Recruiting |
NCT04520646 -
A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy
|
N/A | |
Not yet recruiting |
NCT04529356 -
The TMS Treatment for Postoperative Headache in GH Tumor
|
N/A | |
Active, not recruiting |
NCT03252353 -
Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly
|
Phase 3 |